- Role of phytosterols in the treatment of hypercholesterolaemia2005 | Faculty of Medicine in Hradec Králové
- Evolokumab for the treatment of familial hypercholesterolaemia2017 | Faculty of Medicine in Hradec Králové
- Treating hypercholesterolaemia with evolocumab +12018 | First Faculty of Medicine
- Diagnosis of Familial Hypercholesterolaemia on First Sight? The Role of the Ophthalmologist in Identifying Patients with Familial Hypercholesterolaemia2018 | First Faculty of Medicine
- Renaissance of interest in familial hypercholesterolaemia a fashion trend or consequence of new findings?2012 | First Faculty of Medicine
- The impact of lipoperoxidation monitoring in familiar hypercholesterolaemia treated by extracorporeal elimination2009 | Faculty of Medicine in Hradec Králové
- The impact of lipoperoxidation monitoring in familiar hypercholesterolaemia treated by extracorporeal elimination2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- The impact of lipoperoxidation monitoring in familiar hypercholesterolaemia treated by extracorporeal elimination2009 | First Faculty of Medicine
- News about familial hypercholesterolaemia for cardiologists2019 | First Faculty of Medicine
- Project MedPed - spotlight on patients with familial hypercholesterolaemia2016 | First Faculty of Medicine
- Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study2024 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- The commentary on the study: The efficacy of alicumab in patients with hypercholesterolaemia, depending on the type and dose of co-administered statin - a combined analysis of 8 clinical trials2017 | Faculty of Medicine in Hradec Králové
- What is the most important for patients with familial hypercholesterolaemia? MedPed project in the Czech and Slovak Republic2016 | First Faculty of Medicine
- Analysis of circulating miRNAs in patients with familial hypercholesterolaemia treated by LDL/Lp(a) apheresis2017 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration2016 | First Faculty of Medicine
- Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia2010 | First Faculty of Medicine
- Familial hypercholesterolaemia - A diagnosis that every plastic surgeon can experience2018 | First Faculty of Medicine
- Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries2020 | First Faculty of Medicine
- ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia2015 | First Faculty of Medicine
- Two pediatric casuistics in patients with primar hypercholesterolaemia2000 | Central Library of Charles University, Second Faculty of Medicine
- Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries2021 | First Faculty of Medicine
- Role of lomitapide in treatment of severe familial hypercholesterolaemia2020 | Faculty of Medicine in Hradec Králové
- Lipoprotein apheresis as a method of choice in the treatment of patients with severe hypercholesterolaemia2017 | Faculty of Medicine in Hradec Králové
- Leukocyte but not endothelial cell adhesion molecules are increased in patients with hypercholesterolaemia: the effect of atorvastatin treatmentPublication without faculty affiliation
- Haemostasis and LDL-apheresis in familial hypercholesterolaemiaPublication without faculty affiliation
- Familiar hypercholesterolaemia - combinet hetorozygote or homozygote?Publication without faculty affiliation
- Dual inhibition - a new perspective of the treatment of hypercholesterolaemia2003 | First Faculty of Medicine
- Treatment of children and adolescents with hypercholesterolaemia and dyslipidaemia1998 | Faculty of Physical Education and Sport
- Cholesterol and atherosclerosis2012 | First Faculty of Medicine